August 30, 2016 10:22 AM ET

Biotechnology

Company Overview of Juno Therapeutics Inc.

Executive Profile

Jeffrey A. Bluestone Ph.D., M.D., AW,UCSF

Scientific Advisor, Juno Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 9 different industries.

See Board Relationships
----

Background

Mr. Jeffrey A. Bluestone, also known as Jeff, PhD., MD, AW, UCSF, serves as a Mary Margaret Clausen Distinguished Professor of Medicine, Pathology, Microbiology & Immunology at the University of California, San Francisco (UCSF). Mr. Bluestone served as a Consultant at EpiVax, Inc. He is an expert in diabetes and immunology. He serves as Immune Modulation Program Advisor and Member of Type 1 Diabetes Scientific Advisory Board at Caladrius Biosciences, Inc. He serves as ...

Corporate Headquarters

307 Westlake Avenue North
Seattle, Washington 98109

United States

Phone: 206-582-1600
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

MS
Rutgers, The State University of New Jersey
BS
Rutgers, The State University of New Jersey
PhD
Weill Cornell Graduate School of Medical Sciences

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Randal J. Kirk J.D.Chairman and Chief Executive Officer
Intrexon Corporation
$4.4M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Juno Therapeutics Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.